Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
Earnings Data
Report Date
Apr 22, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
10.58Last Year’s EPS
11.97Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call balanced significant near-term challenges—notably membership declines (Medicaid and Medicare), elevated cost trends, a negative Medicaid margin expectation for 2026, and a lower 2026 EPS baseline versus 2025—with several constructive positives: strong Q4 revenue, Carillon growth and external demand, disciplined pricing and portfolio repositioning, targeted investments in analytics and care management, healthy ASO sales momentum, and a clear plan to return to at least 12% EPS growth in 2027. Management emphasized prudent assumptions and execution, but material near-term headwinds and margin recalibrations reduce upside in 2026.Company Guidance
Strong Q4 and FY2025 Adjusted EPS
Reported adjusted diluted EPS of $3.33 in Q4 and $30.29 for full-year 2025; FY2025 results included approximately $3.75 per share of favorable nonrecurring items.
Q4 Revenue Growth
Operating revenue for the fourth quarter totaled $49.3 billion, an increase of 10% year-over-year, driven by premium rate adjustments, higher cost trend recognition, and recent acquisitions.
2026 Guidance and Path to 2027 Growth
Established 2026 adjusted diluted EPS guidance of at least $25.50 and reaffirmed a long-term algorithm targeting at least 12% adjusted EPS growth in 2027 off the 2026 baseline.
Carillon Momentum and External Growth
Carillon reported strong customer demand: services grew nearly 60% in 2025 and pharmacy grew over 20% in 2025; external services growth (adjusting for internal headwinds) would have been high-teens to low-twenties and Rx low-double-digits.
Member-Facing & Digital Progress
Patient advocacy programs now serve over 7 million members, up nearly 20% year-over-year; committed to >80% of prior authorization decisions in real time by 2027 and continued rollout of the HealthOS platform for real-time data exchange.
Capital Return and Liquidity
Repurchased $2.6 billion of shares in 2025 (1.4 million shares / $470 million in Q4) and returned $4.1 billion to shareholders; plan to allocate approximately $2.3 billion to share repurchases in 2026 and expect operating cash flow of at least $5.5 billion in 2026 (vs $4.3 billion in 2025).
Disciplined Commercial / ASO Performance
Commercial business (especially national accounts / ASO) showed healthy momentum with a productive selling season and strong retention; won 9 of 11 second-blue bids cited as evidence of sales strength.
Targeted Cost Management and Analytics
Company is scaling analytics to identify outlier utilization (e.g., SUD treatment), strengthening specialty pharmacy management and behavioral health support, and expanding care management programs to control elevated utilization trends.
ELV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ELV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jan 28, 2026 | $322.92 | $341.85 | +5.86% |
Oct 21, 2025 | $352.25 | $347.96 | -1.22% |
Jul 17, 2025 | $340.92 | $299.27 | -12.22% |
Apr 22, 2025 | $400.64 | $409.71 | +2.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Elevance Health (ELV) report earnings?
Elevance Health (ELV) is schdueled to report earning on Apr 22, 2026, Before Open (Confirmed).
What is Elevance Health (ELV) earnings time?
Elevance Health (ELV) earnings time is at Apr 22, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ELV EPS forecast?
ELV EPS forecast for the fiscal quarter 2026 (Q1) is 10.58.
